C4 Therapeutics, Inc. (CCCC) vs Mobia Medical, Inc. Common Stock (MOBI)

A side-by-side comparison of C4 Therapeutics, Inc. and Mobia Medical, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CCCC vs MOBI

growth of $100 · dividends reinvested · last 1y
CCCC +0.7% (+0.7%/yr)MOBI -36.1% (-36.1%/yr)CCCC compounded faster over this window
6080100120140160Start $100$101$64
CCCC MOBI

CCCC vs MOBI: by the numbers

  • •CCCC is the larger company ($315M vs $296M market cap).
  • •Both run net losses; MOBI's is the smaller (-145.12% vs -289.44% net margin).

Metrics side by side

Valuation

MetricCCCCMOBI
P/S ratio8.99N/A
P/B ratio1.271.72

Profitability

MetricCCCCMOBI
Gross margin77.81%81.07%
Operating margin-290.68%-144.71%
Net margin-289.44%-145.12%
ROE-41.02%N/A
ROIC-35.92%-122.21%

Growth (annualized)

MetricCCCCMOBI
Revenue CAGR (5Y)0.65%N/A
Total return CAGR (5Y)-41.77%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.